SIPPET study results published in the “New England Journal of Medicine”
This investigator-initiated clinical study involved 42 hemophilia treatment centers from all over the world
Italian TV broadcasted report on CURhE, global initiative supported by Kedrion Biopharma
RAI’s medical special featured Italian neonatologist Giuseppe Buonocore, one of the founders of the Consortium
Kedrion Biopharma for Mother’s Day
We are committed to helping eliminate Rh disease worldwide by supporting initiatives like CURhE
CURhE, Global Alliance for mother and child healthcare
Kedrion among the founding members. The aim is Rh disease eradication
“Chez nous, le cirque!” clown doctors at Barga hospital with Kedrion Biopharma
The company engaged in a social responsibility initiative at the San Francesco hospital
Kedrion Biopharma strengthens its position on the US market
Granted exclusive rights to commercialize a lifesaving drug in the US
A brand new location for KEDPlasma donors in the very center of Fürth
Plasma collected is turned into life-saving therapies to serve patients in Germany and worldwide
KEDPlasma acquires two plasma centers from ImmunoTek LLC in the US
The acquisition is part of a five-year growth plan of supplying highest-quality plasma to Kedrion Biopharma
“Vita” technical college in Siena opens registrations for its first course
The course will be held in Florence over the next two years, and it will train biomedical devices manufacturing technicians
Kedrion supports Fondazione Paracelso’s activities in Afghanistan
Kedrion confirms its commitment to broaden access to hemophilia treatments in developing Countries